C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 295/145 (2006.01) A61K 31/275 (2006.01) A61K 31/40 (2006.01) A61K 31/41 (2006.01) A61K 31/4453 (2006.01) A61K 31/5375 (2006.01) A61P 27/02 (2006.01) C07D 231/12 (2006.01) C07D 233/61 (2006.01) C07D 249/08 (2006.01)
Patent
CA 2650900
Water- and lipid-soluble cannabinoid compounds that are agonists for CBl and CB2 receptors are provided. The cannabinoid compounds are useful for the treatment of retinal neurodegenerative disorders such as glaucoma, diabetic retinopathy and macular degeneration.
La présente invention concerne de composés cannabinoïdes hydrosolubles et liposolubles qui sont des agonistes des récepteurs CBl et CB2. Les composés cannabinoïdes sont utiles pour le traitement de troubles neurodégénératifs rétiniens tels que le glaucome, la rétinopathie diabétique et la dégénérescence maculaire.
Lattanzio Frank A.
Martin Billy R.
Razdan Raj K.
Samudre Sandeep
Williams Patricia B.
Bennett Jones Llp
Eastern Virginia Medical School
Organix Inc.
Virginia Commonwealth University
LandOfFree
Novel cannabinoids and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel cannabinoids and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel cannabinoids and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1568615